Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 1, Pages e1030-e1030
Publisher
Springer Nature
Online
2014-01-30
DOI
10.1038/cddis.2013.557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: An experiment in vivo
- (2012) Ming Xu et al. ACTA RADIOLOGICA
- Hypertrophy and Unconventional Cell Division of Hepatocytes Underlie Liver Regeneration
- (2012) Yuichiro Miyaoka et al. CURRENT BIOLOGY
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma
- (2012) Daniele Santini et al. Expert Review of Anticancer Therapy
- Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice
- (2012) Yulia A. Nevzorova et al. HEPATOLOGY
- Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
- (2012) C Dudgeon et al. ONCOGENE
- Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration
- (2012) M. K. Diril et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
- (2011) Yue-Lei Chen et al. HEPATOLOGY
- Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
- (2011) Monica Marra et al. Journal of Translational Medicine
- Latest developments in targeted therapy for hepatocellular carcinoma
- (2010) Liliana Montella et al. Expert Review of Anticancer Therapy
- Effect of sorafenib on murine liver regeneration
- (2010) Caroline Hora et al. HEPATOLOGY
- p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice
- (2010) Song Chen et al. JOURNAL OF HEPATOLOGY
- New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
- (2010) Yan Wang et al. JOURNAL OF HEPATOLOGY
- Aberrant Cell Cycle Progression and Endoreplication in Regenerating Livers of Mice That Lack a Single E-Type Cyclin
- (2009) Yulia A. Nevzorova et al. GASTROENTEROLOGY
- The liver's dance with death: Two Bcl-2 guardian proteins from the abyss
- (2009) Sophie C. Cazanave et al. HEPATOLOGY
- Death through a tragedy: mitotic catastrophe
- (2008) H Vakifahmetoglu et al. CELL DEATH AND DIFFERENTIATION
- Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes
- (2008) Binje Vick et al. HEPATOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Molecular Dissection of gp130-dependent Pathways in Hepatocytes during Liver Regeneration
- (2008) Uta Dierssen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started